These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25223306)

  • 1. The influence of adnectin binding on the extracellular domain of epidermal growth factor receptor.
    Iacob RE; Chen G; Ahn J; Houel S; Wei H; Mo J; Tao L; Cohen D; Xie D; Lin Z; Morin PE; Doyle ML; Tymiak AA; Engen JR
    J Am Soc Mass Spectrom; 2014 Dec; 25(12):2093-102. PubMed ID: 25223306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fast photochemical oxidation of proteins (FPOP) maps the epitope of EGFR binding to adnectin.
    Yan Y; Chen G; Wei H; Huang RY; Mo J; Rempel DL; Tymiak AA; Gross ML
    J Am Soc Mass Spectrom; 2014 Dec; 25(12):2084-92. PubMed ID: 25267085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural evaluation of EGFR inhibition mechanisms for nanobodies/VHH domains.
    Schmitz KR; Bagchi A; Roovers RC; van Bergen en Henegouwen PM; Ferguson KM
    Structure; 2013 Jul; 21(7):1214-24. PubMed ID: 23791944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matuzumab binding to EGFR prevents the conformational rearrangement required for dimerization.
    Schmiedel J; Blaukat A; Li S; Knöchel T; Ferguson KM
    Cancer Cell; 2008 Apr; 13(4):365-73. PubMed ID: 18394559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational Assessment of Adnectin and Adnectin-Drug Conjugate by Hydrogen/Deuterium Exchange Mass Spectrometry.
    Huang RY; O'Neil SR; Lipovšek D; Chen G
    J Am Soc Mass Spectrom; 2018 Jul; 29(7):1524-1531. PubMed ID: 29736601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells.
    Wood ER; Truesdale AT; McDonald OB; Yuan D; Hassell A; Dickerson SH; Ellis B; Pennisi C; Horne E; Lackey K; Alligood KJ; Rusnak DW; Gilmer TM; Shewchuk L
    Cancer Res; 2004 Sep; 64(18):6652-9. PubMed ID: 15374980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains.
    Ogiso H; Ishitani R; Nureki O; Fukai S; Yamanaka M; Kim JH; Saito K; Sakamoto A; Inoue M; Shirouzu M; Yokoyama S
    Cell; 2002 Sep; 110(6):775-87. PubMed ID: 12297050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for EGF receptor inhibition by the therapeutic antibody IMC-11F8.
    Li S; Kussie P; Ferguson KM
    Structure; 2008 Feb; 16(2):216-27. PubMed ID: 18275813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biophysical Evidence for Intrinsic Disorder in the C-terminal Tails of the Epidermal Growth Factor Receptor (EGFR) and HER3 Receptor Tyrosine Kinases.
    Keppel TR; Sarpong K; Murray EM; Monsey J; Zhu J; Bose R
    J Biol Chem; 2017 Jan; 292(2):597-610. PubMed ID: 27872189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transitions to catalytically inactive conformations in EGFR kinase.
    Shan Y; Arkhipov A; Kim ET; Pan AC; Shaw DE
    Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7270-5. PubMed ID: 23576739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structures of adnectin/protein complexes reveal an expanded binding footprint.
    Ramamurthy V; Krystek SR; Bush A; Wei A; Emanuel SL; Das Gupta R; Janjua A; Cheng L; Murdock M; Abramczyk B; Cohen D; Lin Z; Morin P; Davis JH; Dabritz M; McLaughlin DC; Russo KA; Chao G; Wright MC; Jenny VA; Engle LJ; Furfine E; Sheriff S
    Structure; 2012 Feb; 20(2):259-69. PubMed ID: 22325775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro phosphorylation of the epidermal growth factor receptor autophosphorylation domain by c-src: identification of phosphorylation sites and c-src SH2 domain binding sites.
    Lombardo CR; Consler TG; Kassel DB
    Biochemistry; 1995 Dec; 34(50):16456-66. PubMed ID: 8845374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erlotinib binds both inactive and active conformations of the EGFR tyrosine kinase domain.
    Park JH; Liu Y; Lemmon MA; Radhakrishnan R
    Biochem J; 2012 Dec; 448(3):417-23. PubMed ID: 23101586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for EGFR ligand sequestration by Argos.
    Klein DE; Stayrook SE; Shi F; Narayan K; Lemmon MA
    Nature; 2008 Jun; 453(7199):1271-5. PubMed ID: 18500331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface.
    Zhang X; Pickin KA; Bose R; Jura N; Cole PA; Kuriyan J
    Nature; 2007 Nov; 450(7170):741-4. PubMed ID: 18046415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adnectin-Based Design of Chimeric Antigen Receptor for T Cell Engineering.
    Han X; Cinay GE; Zhao Y; Guo Y; Zhang X; Wang P
    Mol Ther; 2017 Nov; 25(11):2466-2476. PubMed ID: 28784559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The extracellular domain of the epidermal growth factor receptor. Studies on the affinity and stoichiometry of binding, receptor dimerization and a binding-domain mutant.
    Brown PM; Debanne MT; Grothe S; Bergsma D; Caron M; Kay C; O'Connor-McCourt MD
    Eur J Biochem; 1994 Oct; 225(1):223-33. PubMed ID: 7925442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A molecular view of anti-ErbB monoclonal antibody therapy.
    Leahy DJ
    Cancer Cell; 2008 Apr; 13(4):291-3. PubMed ID: 18394550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric regulation of epidermal growth factor (EGF) receptor ligand binding by tyrosine kinase inhibitors.
    Macdonald-Obermann JL; Pike LJ
    J Biol Chem; 2018 Aug; 293(35):13401-13414. PubMed ID: 29997256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A specific amino acid context in EGFR and HER2 phosphorylation sites enables selective binding to the active site of Src homology phosphatase 2 (SHP2).
    Hartman Z; Geldenhuys WJ; Agazie YM
    J Biol Chem; 2020 Mar; 295(11):3563-3575. PubMed ID: 32024694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.